&Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
5,472
+1,356
+33% +$115K ﹤0.01% 1310
2026
Q1
$355K Sell
4,116
-1,216
-23% -$109K ﹤0.01% 1884
2025
Q4
$466K Buy
5,332
+534
+11% +$40.5K ﹤0.01% 1646
2025
Q3
$275K Buy
4,798
+1,115
+30% +$64.2K ﹤0.01% 1806
2025
Q2
$219K Buy
+3,683
New +$238K ﹤0.01% 1789

Other funds holding GMED

&Partners's GMED Position: Q2 2026 in Review

&Partners increased its Globus Medical (GMED) stake by 33% in Q2 2026, buying an estimated $115K and bringing the position to 5,472 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

&Partners first reported a position in GMED in Q2 2025 and has held it in 5 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • &Partners held 5,472 shares of Globus Medical worth $1.18M as of Q2 2026.
  • &Partners bought 1,356 Globus Medical shares in Q2 2026, an estimated $115K.
  • Globus Medical made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1310 holding.
  • &Partners first reported a position in Globus Medical in Q2 2025 and has held it in 5 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.